Compounds > quinoxalines
Page last updated: 2024-08-17

quinoxalines and T-Cell Lymphoma

quinoxalines has been researched along with T-Cell Lymphoma in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bompart, J; Bonnet, PA; Bressolle, FM; Cooper, JF; Deleuze-Masquéfa, C; El Messaoudi, S; Gattacceca, F; Khier, S; Lafaille, F; Pinguet, F; Solassol, I1
Bazarbachi, A; Bonnet, PA; Deleuze-Masquéfa, C; El-Hajj, H; El-Sabban, ME; Hermine, O; Kfoury, Y; Lepelletier, Y; Moarbess, G1
Ahmadi, MA; Anderlini, P; Esmaeli, B; Kim, RY; Naderi, AA; Rivera, P1

Other Studies

3 other study(ies) available for quinoxalines and T-Cell Lymphoma

ArticleYear
Metabolism and pharmacokinetics of EAPB0203 and EAPB0503, two imidazoquinoxaline compounds previously shown to have antitumoral activity on melanoma and T-lymphomas.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:10

    Topics: Animals; Antineoplastic Agents; Biotransformation; Blood Proteins; Dogs; Humans; Lymphoma, T-Cell; Melanoma; Mice; Microsomes, Liver; Molecular Structure; Protein Binding; Quinoxalines; Rats; Rats, Sprague-Dawley; Species Specificity; Spectrometry, Mass, Electrospray Ionization; Tissue Distribution

2010
EAPB0203, a member of the imidazoquinoxaline family, inhibits growth and induces caspase-dependent apoptosis in T-cell lymphomas and HTLV-I-associated adult T-cell leukemia/lymphoma.
    Blood, 2008, Apr-01, Volume: 111, Issue:7

    Topics: Aminoquinolines; Antineoplastic Agents; Apoptosis; bcl-X Protein; Caspases; Cell Division; Cytochromes c; G2 Phase; Human T-lymphotropic virus 1; Humans; Imiquimod; Inflammation; Inhibitor of Apoptosis Proteins; Jurkat Cells; Leukemia-Lymphoma, Adult T-Cell; Lymphocyte Activation; Lymphoma, T-Cell; Membrane Potential, Mitochondrial; NF-kappa B; Quinoxalines; Skin Neoplasms; Tumor Suppressor Protein p53

2008
Scleritis as the initial clinical manifestation of graft-versus-host disease after allogenic bone marrow transplantation.
    American journal of ophthalmology, 2002, Volume: 133, Issue:6

    Topics: Acetazolamide; Bone Marrow Transplantation; Brimonidine Tartrate; Choroid Diseases; Drug Therapy, Combination; Graft vs Host Disease; Humans; Lymphoma, T-Cell; Male; Methylprednisolone; Middle Aged; Pain; Quinoxalines; Scleritis; Transplantation, Homologous

2002